Skip to main content
. 2022 Nov 24;22:409. doi: 10.1186/s12893-022-01850-2

Table 1.

Clinicopathological characteristics of the enrolled patient

Clinical parameter
Gender
 Male 19 (55.9%)
 Female 15 (44.1%)
Age (mean ± SD, year) 56.29 ± 12.71
Primary or Recurrence
 Primary 18 (52.9%)
 Recurrence 16 (47.1%)
Multiple Lesions
 Yes 11 (32.4%)
 No 23 (67.6%)
Tumor Size (mean ± SD, cm) 19.0 ± 12.7
Histology
 LPS 15 (44.1%)
 GIST 14 (41.2%)
 LMS 4 (11.8%)
 DT 1 (2.9%)
Multivisceral Resection
 Yes 23 (67.6%)
 No 11 (32.4%)
Combined Pancreatic Resection*
 Yes 9 (26.5%)
 No 25 (73.5%)
Anastomosis Style
 S-style 21 (62.8%)
 E-style 13 (38.2%)
 Operation Time (mean ± SD, min) 344 ± 121
 Intraoperative Blood Loss (mean ± SD, ml) 1294 ± 1342
Complication
 Grade 1–2 22 (64.7%)
 Grade 3–5 12 (35.3%)
Delayed Gastric Emptying
 Yes 12 (35.3%)
 No 22 (64.7%)
Incision Infection
 Yes 11 (32.4%)
 No 23 (67.6%)
Intraperitoneal Infection
 Yes 14 (41.2%)
 No 20 (58.8%)
Duodenojejunal anastomotic Fistula
 Yes 6 (17.6%)
 No 28 (82.4%)
Pancreatic Fistula
 Yes 7 (20.6%)
 No 27 (79.4%)
Postoperative Massive Hemorrhage
 Yes 3 (8.8%)
 No 31 (91.2%)
Re-operation
 Yes 3 (8.8%)
 No 31 (91.2%)
Time to Feed (mean ± SD, day) 18.8 ± 20.1
Postoperative Hospital stay (mean ± SD, day) 27.0 ± 20.2

LPS: liposarcoma; LMS: leiomyosarcoma; GIST: gastrointestinal stromal tumor; DT: desmoid tumor; SD: stand deviation

*Refers to the removal of the uncinate or the body and tail of the pancreas